Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Ginkgo Bioworks
DNA
$637M
| $706K | ﹤0.01% |
52,763
+800
| +2% | +$10.7K |
|
2327
Scholar Rock
SRRK
$3.04B
| $701K | ﹤0.01% |
84,200
+5,900
| +8% | +$49.1K |
|
2328
Lightwave Logic
LWLG
$399M
| $701K | ﹤0.01% |
234,400
+16,300
| +7% | +$48.7K |
|
2329
National Research Corp
NRC
$363M
| $700K | ﹤0.01% |
30,500
-1,000
| -3% | -$23K |
|
2330
Resources Connection
RGP
$172M
| $697K | ﹤0.01% |
63,100
| – | – |
|
2331
The RMR Group
RMR
$287M
| $696K | ﹤0.01% |
30,792
| – | – |
|
2332
Kura Sushi USA
KRUS
$970M
| $694K | ﹤0.01% |
11,000
-1,100
| -9% | -$69.4K |
|
2333
Perspective Therapeutics
CATX
$255M
| $691K | ﹤0.01% |
+69,260
| New | +$691K |
|
2334
Methode Electronics
MEI
$261M
| $690K | ﹤0.01% |
66,700
| – | – |
|
2335
Petco
WOOF
$1.02B
| $685K | ﹤0.01% |
181,300
| – | – |
|
2336
Root
ROOT
$1.52B
| $681K | ﹤0.01% |
+13,200
| New | +$681K |
|
|
ITOS
2337
DELISTED
iTeos Therapeutics
ITOS
| $681K | ﹤0.01% |
45,900
| – | – |
|
2338
Haverty Furniture Companies
HVT
$383M
| $678K | ﹤0.01% |
26,800
| – | – |
|
2339
Tejon Ranch
TRC
$456M
| $675K | ﹤0.01% |
39,580
-2,600
| -6% | -$44.4K |
|
2340
NewAmsterdam Pharma
NAMS
$2.83B
| $674K | ﹤0.01% |
+35,100
| New | +$674K |
|
2341
Phibro Animal Health
PAHC
$1.6B
| $672K | ﹤0.01% |
40,100
| – | – |
|
2342
Mercer International
MERC
$214M
| $672K | ﹤0.01% |
78,672
| – | – |
|
2343
Clear Channel Outdoor Holdings
CCO
$666M
| $671K | ﹤0.01% |
475,600
-47,800
| -9% | -$67.4K |
|
2344
Liberty Latin America Class A
LILA
$1.57B
| $669K | ﹤0.01% |
69,600
| – | – |
|
2345
Allogene Therapeutics
ALLO
$253M
| $669K | ﹤0.01% |
287,000
+72,200
| +34% | +$168K |
|
|
CNSL
2346
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $668K | ﹤0.01% |
151,747
| – | – |
|
2347
Paymentus
PAY
$4.48B
| $667K | ﹤0.01% |
35,100
+1,200
| +4% | +$22.8K |
|
2348
CryoPort
CYRX
$503M
| $665K | ﹤0.01% |
96,300
| – | – |
|
2349
iRadimed
IRMD
$914M
| $659K | ﹤0.01% |
15,000
-1,200
| -7% | -$52.7K |
|
2350
CureVac
CVAC
$1.21B
| $658K | ﹤0.01% |
198,547
| – | – |
|